A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00642018
Recruitment Status : Completed
First Posted : March 24, 2008
Last Update Posted : June 1, 2012
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2011
  Actual Study Completion Date : April 2012
  Certification/Extension First Submitted : May 24, 2012